Divisions & Programs

Basic and Translational Cancer Research

The laboratories of Gerald Bronfman Department of Oncology faculty members who conduct basic and translational research in cancer are located at McGill (Rosalind and Morris Goodman Cancer Research Centre) and its affiliated hospitals (Jewish General Hospital, McGill University Health Centre).  Research interests are extensive in scope and cover various types of cancers including breast, prostate, colorectal, ovarian, neurological and pediatric cancers. In addition to research, faculty members are also involved in the teaching and training of the next generation of cancer researchers.

Basic and Translational Cancer Research

Rosalind and Morris Goodman Cancer Research Centre

Research at the Rosalind & Morris Goodman Cancer Research Centre (GCRC) focuses on the biochemical, cellular and molecular mechanisms involved in tumourigenesis. A wide range of areas are under investigation, including signal transduction, differentiation, cell proliferation and apoptosis. Many of the cancer researchers located at the hospital-based laboratories are associate members of the GCRC.

GCRC Director: Dr. Morag Park
                             514-398-5749

GCRC General Information: 514-398-3535

 

Jewish General Hospital (Lady Davis Institute/Segal Cancer Centre)

At the Jewish General Hospital basic and translational cancer research is conducted at the Lady Davis Institute/Segal Cancer Centre (LDI/SCC). Research areas include cancer progression, cancer genomics, targeted new therapies, novel molecular targets, cell and gene therapy in cancer, cancer prevention and cancer genetics. Research is facilitated by the presence of a number of core facilities including the cell processing centre, flow cytometry facility, clinical proteomics facility, pathology research facility, high performance computing facility, peptide synthesis laboratory, cell imaging facility and the Clinical Research Unit for Phase I and early Phase II clinical trials. Many of the researchers at the Segal Cancer Centre are members of the McGill Centre for Translational Research in Cancer (MCTRC).

MCTRC Director: Dr. Gerald Batist
                                514-340-8222 x5418

Administration: Angela Fragomene
                           514-340-8222 x5418

 

Cancer Research Program (CRP) of the Research Institute of the McGill University Health Centre (RI-MUHC)

The Cancer Research Program (CRP) is composed of three parts in a new state-of-the-art facility that includes: 1) basic cancer research at the Centre for Translational Biology (CTB), a building connected to the hospital, that houses 120 principle investigators including 26 CRP members; 2) clinical cancer research at the Centre for Innovative Medicine (CIM), which occupies an entire floor of the hospital and includes 12 phase I trial beds; and 3) evaluative cancer research at the Centre for Outcomes Research and Evaluation (CORE), that houses 80 investigators including 20 who study cancer. All three components together constitute the CRP and are located side-by-side at the MUHC Glen Site. Integration of all three groups results in research that is patient centered and incorporates basic, clinical and evaluative science. The activities of the CRP are supported by several Technology Platforms that include: Flow Cytometer and Cell sorting, Cellular Imaging, Tissue Banking, Proteomics and Systems Medicine, Microscopy, Molecular Pathology and Small Animal Imaging. As a result, the program can pursue precision care research especially with the MUHC Cedars Cancer Centre within the same complex.  The focus of the CRP is on the mechanisms of etiology (hereditary predisposition), cancer spread (metastasis) and progression of disease. Research areas include the identification of new markers and therapeutic targets, gene therapy, tumour suppressor genes, angiogenesis and radiosensitivity.

CRP Leader: Dr. Peter Metrakos
                       
514-843-1600

CRP Associate Leader:
Dr. Patricia Tonin

                                         514-934-1934 x44069

 

RESEARCHERS

Rosalind and Morris Goodman Cancer Research Centre Lady Davis Institute/Segal Cancer Centre Cancer Research  Program
RI-MUHC
RI-MUHC  
Nicole Beauchemin Moulay Alaoui-Jamali Armen Aprikian Denis Cournoyer  
Philip Branton Raquel Aloyz Bassam Abdulkarim Phil Gold  
Vincent Giguère Mark Basik Pnina Brodt Nada Jabado  
Philippe Gros Gerald Batist Simone Chevalier Alan Peterson
Luke McCaffrey Christoph Borchers Mario Chevrette Kevin Petrecca  
Alain Nepveu Nicoletta Eliopoulos Issam El Naqa Shafaat Rabbani  
Morag Park Marc Fabian Lorenzo Ferri Janusz Rak  
Jerry Pelletier William Foulkes William Foulkes Robert Turcotte  
Stéphane Richard Walter Gotlieb Siham Sabri
Veena Sangwan Celia Greenwood Michael Sebag    
Peter Siegel Nathalie Johnson Patricia Tonin    
Michel Tremblay Antonis Koromilas
Koren Mann
  Wilson Miller      
  Thierry Muanza      
Miltiadis Paliouras
  Lawrence Panasci      
  Michael Pollak      
  Horacio Uri Saragovi      
  Alan Spatz      
  Ivan Topisirovic       
  Josie Ursini-Siegel      
  Michael Witcher      
Jian Hui Wu